Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC 70010-001-03
Published January 15, 2025 · Recall initiated: December 18, 2024
Summary
FDA records drug Class II recall D-0187-2025, published January 15, 2025 and initiated December 18, 2024. Recalling firm: Granules Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 96 Bottles; Lot: Lot#: GPC240763B, Exp. Date 6/17/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.
What to do
Voluntary: Firm initiated · Letter
Get an email if COLCHICINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- COLCHICINE
- Manufacturer
- Granules Pharmaceuticals Inc.
- Distributor
- Nationwide within the United States
- UPC
- 0370010001039
- Lot
- Lot#: GPC240763B, Exp. Date 6/17/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAProgesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for:January 15, 2025
- FDADuloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDCJanuary 15, 2025
- FDAmedroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd inJanuary 15, 2025
- FDADuloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising PharmJanuary 15, 2025
- FDAClobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, AmnealJanuary 15, 2025
- FDADuloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30) and b) 1000 count (NDC 57237-019-99) bottles;January 15, 2025
Questions about this recall
Was Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC 70010-001-03 recalled?
Yes. FDA published recall D-0187-2025 on January 15, 2025. Reported hazard: Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: COLCHICINE. UPC: 0370010001039.